Collectively, these studies suggest that not only does APOE4 increase the risk of developing various non-amyloid neuropathologies, but this risk may be synergistically heightened by altered immunomodulation and inhibited ability to respond to neuronal injuries on a synaptic level to maintain proper signaling networks. The gene discussed is APOE; the disease is amyloidosis.